Amanda Vrselja
Program Head, CUREator
Amanda joined Brandon Capital in 2021.
Prior to joining Brandon Capital, Amanda was a Clinical Scientist at QUE Oncology, a clinical stage company developing a novel, non-hormonal treatment for vasomotor symptoms. At QUE Oncology, Amanda was involved in the strategic planning and implementation of clinical and R&D project activities, and she oversaw the project management of all functional divisions. Amanda developed her interest in commercialisation during her PhD and was a member of the winning team in the inaugural Australian-French Entrepreneurship Challenge in 2016.
Amanda has a Bachelor of Science (Honours) and a PhD in Developmental Biology from Monash University.
